📣 VC round data is live. Check it out!

Core Laboratories Valuation Multiples

Discover revenue and EBITDA valuation multiples for Core Laboratories and similar public comparables like West Holdings, Total Energy Services, Schoeller-Bleckmann, PetroRecôncavo and more.

Core Laboratories Overview

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.


Founded

1936

HQ

United States

Employees

3.5K

Financials (LTM)

Revenue: $523M
EBITDA: $70M

EV

$784M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Core Laboratories Financials

Core Laboratories reported last 12-month revenue of $523M and EBITDA of $70M.

In the same LTM period, Core Laboratories generated $108M in gross profit, $70M in EBITDA, and $33M in net income.

Revenue (LTM)


Core Laboratories P&L

In the most recent fiscal year, Core Laboratories reported revenue of $527M and EBITDA of $73M.

Core Laboratories is profitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 14%, and net margin of 7%.

See analyst estimates for Core Laboratories
LTMLast FY202320242025202620272028
Revenue$523M$527M$510M$524M$527M
Gross Profit$108M$94M$94M$88M$94M
Gross Margin21%18%18%17%18%
EBITDA$70M$73M$70M$74M$71M
EBITDA Margin13%14%14%14%14%
EBIT Margin10%11%11%10%10%
Net Profit$33M$35M$37M$31M$30M
Net Margin6%7%7%6%6%
Net Debt-$88M---

Financial data powered by Morningstar, Inc.

Core Laboratories Stock Performance

Core Laboratories has current market cap of $639M, and enterprise value of $784M.

Market Cap Evolution


Core Laboratories' stock price is $13.87.

Core Laboratories share price increased by 1.5% in the last 30 days, and by 20.4% in the last year.

Core Laboratories has an EPS (earnings per share) of $0.77.

See more trading valuation data for Core Laboratories
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$784M$639M1.5%1.5%-17.4%20.4%$0.77

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Core Laboratories Valuation Multiples

Core Laboratories trades at 1.5x EV/Revenue multiple, and 11.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Core Laboratories

EV / Revenue (LTM)


Core Laboratories Financial Valuation Multiples

As of June 2, 2026, Core Laboratories has market cap of $639M and EV of $784M.

Core Laboratories has a P/E ratio of 19.6x.

LTMLast FY202320242025202620272028
EV/Revenue1.5x1.5x1.5x1.5x1.5x
EV/EBITDA11.2x10.7x11.1x10.7x11.0x
EV/EBIT15.1x13.4x14.2x15.8x15.5x
EV/Gross Profit7.3x8.3x8.3x8.9x8.3x
P/E19.6x18.1x17.4x20.4x21.5x
EV/FCF34.0x34.7x55.2x18.1x35.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Core Laboratories Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Core Laboratories Margins & Growth Rates

Core Laboratories decreased revenue by 2% and EBITDA by 12% in the last fiscal year.

In the most recent fiscal year, Core Laboratories reported gross margin of 18%, EBITDA margin of 14%, and net margin of 7%.

See estimated margins and future growth rates for Core Laboratories

Core Laboratories Margins

Last FY202420252026202720282029
Gross Margin18%17%18%20%
EBITDA Margin14%14%14%13%
EBIT Margin11%10%10%8%
Net Margin7%6%6%6%
FCF Margin4%8%4%5%

Core Laboratories Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)3%1%(2%)
Gross Profit Growth12%(6%)7%12%
EBITDA Growth(12%)4%(3%)(9%)
EBIT Growth(27%)(10%)1%(15%)
Net Profit Growth(18%)(14%)(6%)(3%)
FCF Growth5%205%(49%)6%

Data powered by FactSet, Inc. and Morningstar, Inc.

Core Laboratories Operational KPIs

Core Laboratories' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Core Laboratories' Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Core Laboratories' Rule of X is 8% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Core Laboratories
LTMLast FY202320242025202620272028
Rule of 4015%11%---
Bessemer Rule of X17%8%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue9%9%8%7%8%
Opex to Revenue-8%8%7%8%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Core Laboratories Competitors

Core Laboratories competitors include West Holdings, Total Energy Services, Schoeller-Bleckmann, PetroRecôncavo, Granite Ridge Resources, WIP Terminal, Surge Energy, W&T Offshore, Capex and Mitsuuroko Group Holdings.

Most Core Laboratories public comparables operate across Energy Equipment and Oil & Gas.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
West Holdings3.1x2.8x13.4x-
Total Energy Services0.8x0.8x4.5x4.2x
Schoeller-Bleckmann1.4x1.4x7.9x8.4x
PetroRecôncavo1.5x1.6x2.7x3.4x
Granite Ridge Resources2.3x2.1x3.3x3.1x
WIP Terminal----
Surge Energy2.0x1.9x3.9x3.5x
W&T Offshore1.6x1.5x6.6x5.4x

This data is available for Pro users. Sign up to see all Core Laboratories competitors and their valuation data.

Start Free Trial

Core Laboratories M&A Activity

Core Laboratories has acquired 1 company to date.

Last acquisition by Core Laboratories was on September 30th 2025. Core Laboratories acquired Solintec for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Core Laboratories

Solintec
Description
Solintec is a Rio de Janeiro-based geological services provider for upstream oil and gas. It offers wellsite geology, core analysis, biostratigraphy, and fluid characterization from its labs in Brazil. Serving Petrobras and international operators, Solintec maintains sample repositories exceeding 1 million cuttings boxes.
HQ CountryBrazil
HQ City
São Paulo
Deal Date30 Sep 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Core Laboratories acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Core Laboratories

When was Core Laboratories founded?Core Laboratories was founded in 1936.
Where is Core Laboratories headquartered?Core Laboratories is headquartered in United States.
How many employees does Core Laboratories have?As of today, Core Laboratories has over 3K employees.
Who is the CEO of Core Laboratories?Core Laboratories' CEO is Lawrence Bruno.
Is Core Laboratories publicly listed?Yes, Core Laboratories is a public company listed on NYSE.
What is the stock symbol of Core Laboratories?Core Laboratories trades under CLB ticker.
When did Core Laboratories go public?Core Laboratories went public in 1995.
Who are competitors of Core Laboratories?Core Laboratories main competitors include West Holdings, Total Energy Services, Schoeller-Bleckmann, PetroRecôncavo, Granite Ridge Resources, WIP Terminal, Surge Energy, W&T Offshore, Capex, Mitsuuroko Group Holdings.
What is the current market cap of Core Laboratories?Core Laboratories' current market cap is $639M.
What is the current revenue of Core Laboratories?Core Laboratories' last 12 months revenue is $523M.
What is the current revenue growth of Core Laboratories?Core Laboratories revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Core Laboratories?Current revenue multiple of Core Laboratories is 1.5x.
What is the current EBITDA of Core Laboratories?Core Laboratories' last 12 months EBITDA is $70M.
What is Core Laboratories' EBITDA margin?Core Laboratories' last 12 months EBITDA margin is 13%.
What is the current EV/EBITDA multiple of Core Laboratories?Current EBITDA multiple of Core Laboratories is 11.2x.
What is the current FCF of Core Laboratories?Core Laboratories' last 12 months FCF is $23M.
What is Core Laboratories' FCF margin?Core Laboratories' last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Core Laboratories?Current FCF multiple of Core Laboratories is 34.0x.
How many companies Core Laboratories has acquired to date?As of June 2026, Core Laboratories has acquired 1 company.
What was the largest acquisition by Core Laboratories?None of the M&A deals Core Laboratories has completed have disclosed valuations.
What companies Core Laboratories acquired?Core Laboratories acquired Solintec.
In how many companies Core Laboratories has invested to date?Core Laboratories hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Core Laboratories

Lists including Core Laboratories

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial